Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12857/115809
Title: Imatinib mesylate in desmoplastic small round cell tumors
Authors: De Sanctis, Rita
Bertuzzi, Alexia
Bisogno, Gianni 
Carli, Modesto 
Ferrari, Andrea
Comandone, Alessandro
Santoro, Armando
Keywords: PDGF-Rα;PDGF-Rβ;c-KIT;desmoplastic small round cell tumor;imatinib
Keywords Plus: II CLINICAL-TRIAL;PHASE-II;THERAPY;SARCOMA;PRODUCT
Mesh headings: Desmoplastic Small Round Cell Tumor;Imatinib Mesylate
Secondary Mesh headings: Adolescent;Adult;Child;Female;Gene Expression Regulation, Neoplastic;Humans;Italy;Male;Patient Selection;Proto-Oncogene Proteins c-kit;Receptor, Platelet-Derived Growth Factor alpha;Treatment Failure;Young Adult
Issue Date: Jun-2017
Publisher: FUTURE MEDICINE LTD
Journal: Future oncology (London, England) 
Abstract: 
To investigate the possible role of imatinib, an inhibitor of the tyrosine kinase activity of PDGF-R, in desmoplastic small round cell tumor (DSRCT).
URI: http://hdl.handle.net/20.500.12857/115809
ISSN: 14796694
DOI: 10.2217/fon-2016-0305
Appears in Collections:Articles

Show full item record

PubMed Central
Citations 50

5
Last Week
0
Last month
checked on May 2, 2021

SCOPUSTM   
Citations 50

4
checked on Aug 31, 2020

WEB OF SCIENCETM
Citations

7
checked on Nov 24, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.